Table 9.
MDSS-based δ-maximum scored bridges for the AC domain
Anatomy.Cell | Disease.NeoplasticProcess | Score | S |
---|---|---|---|
tumor cell | pleomorphic xanthoastrocytoma | coh = 0.125 | 7 |
human cell line | small-cell glioblastoma | coh = 1.000 | 2 |
tumour cells | g-cell tumor | coh = 0.333 | 2 |
oligodendroglial cell | oligodendrogliomas | conf = 0.190 | 4 |
neurons | dysplasias | coh = 1.000 | 2 |
multinucleate giant cell | glioblastomas giant cell | coh = 1.000 | 2 |
multinucleate giant cell | subependymal giant cell astrocytoma | coh = 0.130 | 3 |
multinucleate giant cell | tuberous sclerosis syndrome | conf = 0.217 | 5 |
multinucleate giant cell | pleomorphic xanthoastrocytoma | conf = 0.174 | 4 |
spindle cell | subependymal giant cell astrocytoma | coh = 0.400 | 2 |
tumour cell lines | solid tumour childhood | coh = 0.667 | 2 |
Best δ-maximum scored bridges between the Cell and NeoplasticProcess levels for the the AC domain, using our reduction method (MDSS). Interestingness measures used are: cohesion (coh), confidence (conf) and f-measure (f1). The column S indicates the number of documents supporting each bridge.